Unlike «big data» genetic studies, which have loosely linked hundreds of genetic changes to schizophrenia but can not explain varying symptoms, the new study revealed distinct disease versions that may affect large slices of patients and
enable precision treatment design, say the authors.
Not exact matches
This new knowledge is also making
precision medicine a reality by
enabling the development of highly targeted therapies that offer the potential for improved
treatment outcomes, especially for patients battling cancer.
The Oncology Research Information Exchange Network, or ORIEN, is the world's largest
precision collaboration for cancer research, one that will
enable researchers and clinicians to share data to accelerate the development of
precision medicine
treatments.
ORIEN members share de-identified data to accelerate the development of
precision medicine and
treatments, which
enables researchers and clinicians to more quickly match eligible patients to clinical trials and conduct larger and more comprehensive analyses.
With advanced
treatment - planning software and a board - certified radiation oncologist, our cancer patients benefit from customized
treatment plans and sub-millimeter
precision that
enable the delivery of high - dose radiation directly to the tumor with minimum radiation exposure to the surrounding healthy anatomy.
We pride ourselves in utilizing some of the most scientifically advanced technology, combining the best available equipment with software like EclipseTM and Radialogica that
enable our clinical teams to deliver
treatment with
precision, safety and efficacy while capturing information and continually optimizing delivery protocols.